Main useUsed for certain EGFR mutation-positive non-small-cell lung cancers.A brief overview of Japanese approved uses. Check the PMDA label below for product-specific conditions.
- Japan product name
- タグリッソ錠40mg／80mg
- Brand
- Tagrisso
- Generic name
- Osimertinib
- Japanese generic name
- オシメルチニブ
- Chinese name
- 奥希替尼
- Marketing authorization holder
- アストラゼネカ株式会社
- Strengths
- 40 mg / 80 mg
- Dosage form
- tablet
- Therapeutic area
- Oncologie
- Regulatory status
- Rx
- Label updated
- 2026-01-13
- TOKYO MEDI verified
- 2026-09-22
Source officielle
These links go directly to PMDA records for this Japanese product. Professional and patient-facing sources are separated.